Publicaciones en colaboración con investigadores/as de Universitat de Barcelona (154)

2024

  1. Efficacy and safety of corticosteroids for the treatment of community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials

    Journal of Critical Care, Vol. 80

  2. MicroRNA-centered theranostics for pulmoprotection in critical COVID-19

    Molecular Therapy Nucleic Acids, Vol. 35, Núm. 1

  3. MicroRNA-guided drug discovery for mitigating persistent pulmonary complications in critical COVID-19 survivors: A longitudinal pilot study

    British Journal of Pharmacology

  4. Mortality predictors in critically ill patients with severe COVID-19 pneumonia: A multicenter observational study in Colombia

    Acta Colombiana de Cuidado Intensivo

  5. Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine

    The Lancet Respiratory Medicine, Vol. 12, Núm. 4, pp. 305-322

  6. The efficacy of telavancin in comparison with linezolid on endotracheal tube biofilm in pigs with methicillin-resistant Staphylococcus aureus pneumonia

    International Journal of Antimicrobial Agents, Vol. 63, Núm. 2

  7. Viral Pneumonia: From Influenza to COVID-19

    Seminars in Respiratory and Critical Care Medicine

2023

  1. A Novel Approach to Temperature Profiling in Relation to Clinical Outcomes in Oncological Patients with Neutropenia

    American journal of respiratory and critical care medicine

  2. A Simple Procedure to Measure the Tidal Volume Delivered by Mechanical Ventilators: A Tool for Bedside Verification and Quality Control

    Archivos de Bronconeumologia, Vol. 59, Núm. 1, pp. 61-62

  3. Association Between Viscoelastic Characteristics and Sputum Colour in Patients With Bronchiectasis

    Archivos de Bronconeumologia, Vol. 59, Núm. 6, pp. 406-408

  4. Awake Prone Positioning for Non-Intubated COVID-19 Patients with Acute Respiratory Failure: A Meta-Analysis of Randomised Controlled Trials

    Journal of Clinical Medicine, Vol. 12, Núm. 3

  5. Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)

    The Lancet Respiratory Medicine, Vol. 11, Núm. 7, pp. 637-649

  6. Clinical Outcomes of Critical COVID-19 in HIV-Infected Adults: A Propensity Score Matched Analysis

    Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 772-778

  7. Correction: ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia (Intensive Care Medicine, (2023), 49, 6, (615-632), 10.1007/s00134-023-07033-8)

    Intensive Care Medicine

  8. Determining the most accurate 16S rRNA hypervariable region for taxonomic identification from respiratory samples

    Scientific Reports, Vol. 13, Núm. 1

  9. Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting Best Practice

    American Journal of Respiratory and Critical Care Medicine, Vol. 207, Núm. 9, pp. 1134-1144

  10. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

    Intensive Care Medicine, Vol. 49, Núm. 6, pp. 615-632

  11. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

    European Respiratory Journal, Vol. 61, Núm. 4

  12. Editorial: Personalized therapy in ARDS

    Frontiers in Medicine

  13. Efficacy and safety of ceftazidime/avibactam in patients with infections caused by β-lactamase-producing Gram-negative pathogens: A pooled analysis from the Phase 3 clinical trial programme

    Journal of Antimicrobial Chemotherapy, Vol. 78, Núm. 11, pp. 2672-2682